0 CHECKOUT

Global Epilepsy Pipeline Capsule - 2013

  • ID: 2552141
  • April 2013
  • Region: Global
  • 25 pages
  • Fore Pharma

Fore Pharma’s latest report ‘Global Epilepsy Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global epilepsy market. It covers active epilepsy pipeline molecules in clinical trials, preclinical research, and drug discovery.

This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The scope of the report includes information on epilepsy pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Epilepsy pipeline molecules licensing activities are also covered in this report.

Key Features of the Report:
- Epilepsy Pipeline Overview
- Epilepsy Phase 3 Clinical Trial Pipeline
- Epilepsy Phase 2 Clinical Trial Pipeline
- Epilepsy Phase 1 Clinical Trial Pipeline
- Epilepsy Preclinical Research Pipeline
- Epilepsy Drug Discovery Stage Pipeline
- Epilepsy Pipeline in the U.S.
- Epilepsy Pipeline in Europe
- Licensing Activities in Global Epilepsy Market

Note: Product cover images may vary from those shown

1. Epilepsy - Disease Overview
2. Epilepsy Pipeline Overview
3. Epilepsy Pipeline by Geography
3a. Epilepsy Pipeline in Matured Markets
4. Epilepsy Phase 3 Clinical Trial Pipeline Insights
4a. Epilepsy Phase 3 Clinical Trial Pipeline (North America)
4b. Epilepsy Phase 3 Clinical Trial Pipeline (Europe)
4c. Epilepsy Phase 3 Clinical Trial Pipeline (ROW)
5. Epilepsy Phase 2 Clinical Trial Pipeline Insights
5a. Epilepsy Phase 2 Clinical Trial Pipeline (North America)
5b. Epilepsy Phase 2 Clinical Trial Pipeline (Europe)
5c. Epilepsy Phase 2 Clinical Trial Pipeline (ROW)
6. Epilepsy Phase 1 Clinical Trial Pipeline Insights
6a. Epilepsy Phase 1 Clinical Trial Pipeline (North America)
6b. Epilepsy Phase 1 Clinical Trial Pipeline (Europe)
6c. Epilepsy Phase 1 Clinical Trial Pipeline (ROW)
7. Epilepsy Preclinical Research Pipeline Insights
7a. Epilepsy Preclinical Research Pipeline (North America)
7b. Epilepsy Preclinical Research Pipeline (Europe)
7c. Epilepsy Preclinical Research Pipeline (ROW)
8. Epilepsy Drug Discovery Pipeline Insights
8a. Epilepsy Drug Discovery Pipeline (North America)
8b. Epilepsy Drug Discovery Pipeline (Europe)
8c. Epilepsy Drug Discovery Pipeline (ROW)
9. Epilepsy Market – Licensing Activities
10. Appendix
11. Research Methodology
Table 1: Epilepsy Phase 3 Clinical Trial Pipeline in North America (2013)
Table 2: Epilepsy Phase 3 Clinical Trial Pipeline in Europe (2013)
Table 3: Epilepsy Phase 3 Clinical Trial Pipeline in ROW (2013)
Table 4: Epilepsy Phase 2 Clinical Trial Pipeline in North America (2013)
Table 5: Epilepsy Phase 2 Clinical Trial Pipeline in Europe (2013)
Table 6: Epilepsy Phase 2 Clinical Trial Pipeline in ROW (2013)
Table 7: Epilepsy Phase 1 Clinical Trial Pipeline in North America (2013)
Table 8: Epilepsy Phase 1 Clinical Trial Pipeline in Europe (2013)
Table 9: Epilepsy Phase 1 Clinical Trial Pipeline in ROW (2013)
Table 10: Epilepsy Preclinical Research Pipeline in North America (2013)
Table 11: Epilepsy Preclinical Research Pipeline in Europe (2013)
Table 12: Epilepsy Preclinical Research Pipeline in ROW (2013)
Table 13: Epilepsy Drug Discovery Pipeline in North America (2013)
Table 14: Epilepsy Drug Discovery Pipeline in Europe (2013)
Table 15: Epilepsy Drug Discovery Pipeline in ROW (2013)
Table 16: Key Licensing Activities in Global Epilepsy Market
Figure 1: Epilepsy Pipeline Molecules by Clinical Trial Stages (2013)
Figure 2: Epilepsy Pipeline Activities by Geography (2013)
Figure 3: Epilepsy Pipeline Activities in Matured Markets (2013)
Figure 4: Epilepsy Phase 3 Clinical Trial Activities by Geography (2013)
Figure 5: Epilepsy Phase 2 Clinical Trial Activities by Geography (2013)
Figure 6: Epilepsy Phase 1 Clinical Trial Activities by Geography (2013)
Figure 7: Epilepsy Preclinical Research Activities by Geography (2013)
Figure 8: Epilepsy Drug Discovery Activities by Geography (2013)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: A printed copy of the report will be shipped to you.

  • Quick Help: The report will be shipped to you in CD ROM format.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S